GI panel, rfit-ASY-0116

Ended Awarded Last action

Contract number
W81K0015F0124
Awardee
Awarding agency
Obligated
$1,314,067

Award facts

Opportunity
  • W81K0015T0161 Solicitation number
Contract value 97% obligated
$1,360,249.83 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Emigration Canyon, UT 84108, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00015 -$157,631
Funding Only Action P00014 $473,314
Exercise an Option P00013 $0
Supplemental Agreement for work within scope P00012 $257,900
Funding Only Action P00011 $215,414
Supplemental Agreement for work within scope P00010 · BIO fire reagents $186,608
Exercise an Option P00009 $0
Funding Only Action P00008 $169,231
Exercise an Option P00007 $0
Funding Only Action P00006 -$46,183
Supplemental Agreement for work within scope P00005 $0
Funding Only Action P00004 · Blood culture identification panel -$107,707
Funding Only Action P00003 $215,414
Exercise an Option P00002 $0
Other Administrative Action P00001 · BIO fire film array system $107,707
Original award $0
Show all 16

About this award

This federal contract award was issued by the Department of Defense's Medical Command (MEDCOM) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $1,360,249.83 firm-fixed-price delivery order was placed against Biofire's existing General Services Administration (GSA) Federal Supply Schedule (FSS) contract for in-vitro diagnostics, reagents, and tests. The contract is for the supply of a GI PANEL, RFIT-ASY-0116 product, with a completion date of September 30, 2019.

Biofire Diagnostics LLC has received numerous federal contract awards, serving as both a prime contractor and subcontractor for a variety of infectious disease testing products and services to agencies such as the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service. The company holds several indefinite delivery contracts and blanket purchase agreements that allow federal customers to procure Biofire's testing capabilities on an as-needed basis. This particular award did not utilize any set-aside designations.

Quick answers

Who was awarded contract W81K0015F0124?

W81K0015F0124 was awarded to Biofire Diagnostics LLC by Medical Command (Department of the Army) on July 14, 2015.

How much is contract W81K0015F0124 worth?

The government has obligated $1,314,067 on W81K0015F0124. Its current value, with exercised options, is $1,360,250.

Is contract W81K0015F0124 an order under another contract?

Yes. W81K0015F0124 is a delivery order under V797D30085, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract W81K0015F0124 competed?

The extent of competition for W81K0015F0124 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award